Dynamic Transmission Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-5

Value in Health - Tập 15 - Trang 828-834 - 2012
Richard Pitman1, David Fisman2, Gregory S. Zaric3, Maarten Postma4, Mirjam Kretzschmar5, John Edmunds6, Marc Brisson7
1Oxford Outcomes, Oxford, UK
2Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada
3Ivey School of Business, University of Western Ontario, London, ON, Canada
4Unit of PharmacoEpidemiology & PharmacoEconomics (PE2), Department of Pharmacy, University of Groningen, Groningen, The Netherlands
5Julius Centre for Health Sciences & Primary Care, University Medical Centre Utrecht, and Center for Infectious Disease Control, RIVM, Bilthoven, The Netherlands
6Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, UK
7URESP, Centre de Recherche FRSQ du CHA Universitaire de Québec and Département de Médecine Sociale et Préventive, Laval University, Quebec City, QC, Canada

Tài liệu tham khảo

Caro, 2012, Modeling good research practices—overview: A report of the ISPOR-SMDM modeling good research practices task force-1, Value Health, 15, 796, 10.1016/j.jval.2012.06.012

Roberts, 2012, Conceptualizing a model: a report of the ISPOR-SMDM modeling good research practices task force-2, Value Health, 15, 804, 10.1016/j.jval.2012.06.016

Siebert, 2012, State-transition modeling: a report of the ISPOR-SMDM modeling good research practices task force-3, Value Health, 15, 812, 10.1016/j.jval.2012.06.014

Karnon, 2012, Modeling using discrete event simulation: a report of the ISPOR-SMDM modeling good research practices task force-4, Value Health, 15, 821, 10.1016/j.jval.2012.04.013

Briggs, 2012, Model parameter estimation and uncertainty: a report of the ISPOR-SMDM modeling good research practices task force-6, Value Health, 15, 835, 10.1016/j.jval.2012.04.014

Eddy, 2012, Model transparency and validation: a report of the ISPOR-SMDM modeling good research practices task force-7, Value Health, 15, 843, 10.1016/j.jval.2012.04.012

Brisson, 2003, Economic evaluation of vaccination programs: the impact of herd-immunity, Med Decis Making, 23, 76, 10.1177/0272989X02239651

Brisson, 2006, Impact of model, methodological, and parameter uncertainty in the economic analysis of vaccination programs, Med Decis Making, 26, 434, 10.1177/0272989X06290485

Kim, 2008, Cost-effectiveness analyses of vaccination programmes: a focused review of modelling approaches, Pharmacoeconomics, 26, 191, 10.2165/00019053-200826030-00004

Roberts, 2006, Screening for Chlamydia trachomatis: a systematic review of the economic evaluations and modelling, Sex Transm Infect, 82, 193, 10.1136/sti.2005.017517

Kretzschmar, 2009, Mathematical models in infectious disease epidemiology

Anderson, 1991

Jelinek, 2008, Imported falciparum malaria in Europe: 2007 data from TropNetEurop, Euro Surveill, 13, 10.2807/ese.13.07.08038-en

Lindsay, 2010, Assessing the future threat from vivax malaria in the United Kingdom using two markedly different modelling approaches, Malar J, 9, 70, 10.1186/1475-2875-9-70

Lipsitch, 2003, Transmission dynamics and control of severe acute respiratory syndrome, Science, 300, 1966, 10.1126/science.1086616

Lipsitch, 1999, Bacterial vaccines and serotype replacement: lessons from Haemophilus influenzae and prospects for Streptococcus pneumoniae, Emerg Infect Dis, 5, 336, 10.3201/eid0503.990304

Lipsitch, 1997, Vaccination against colonizing bacteria with multiple serotypes, Proc Natl Acad Sci U S A, 94, 6571, 10.1073/pnas.94.12.6571

Brisson, 2003, Varicella vaccination: impact of vaccine efficacy on the epidemiology of VZV, J Med Virol, 70, S31, 10.1002/jmv.10317

Claes, 2009, Cost effectiveness analysis of heptavalent pneumococcal conjugate vaccine in Germany considering herd immunity effects, Eur J Health Econ, 10, 25, 10.1007/s10198-008-0098-1

Bergman, 2008, Cost-effectiveness analysis of a universal vaccination programme with the 7-valent pneumococcal conjugate vaccine (PCV-7) in Sweden, Scand J Infect Dis, 40, 721, 10.1080/00365540802014872

Walker, 2008

Welte, 2005, Costs and effects of chlamydial screening: dynamic versus static modeling, Sex Transm Dis, 32, 474, 10.1097/01.olq.0000161181.48687.cf

Fisman, 2008, The Philadelphia High-School STD Screening Program: key insights from dynamic transmission modeling, Sex Transm Dis, 35, S61, 10.1097/OLQ.0b013e3181802822

Galvani, 2007, Long-standing influenza vaccination policy is in accord with individual self-interest but not with the utilitarian optimum, Proc Natl Acad Sci U S A, 104, 5692, 10.1073/pnas.0606774104

Brisson, 2000, Modelling the impact of immunization on the epidemiology of varicella zoster virus, Epidemiol Infect, 125, 651, 10.1017/S0950268800004714

Berge, 2000, The cost of hepatitis A infections in American adolescents and adults in 1997, Hepatology, 31, 469, 10.1002/hep.510310229

Fine, 1985, The TORCH syndrome: a clinical review, J Am Acad Dermatol, 12, 697, 10.1016/S0190-9622(85)70095-3

2000, Measles, rubella, and congenital rubella syndrome--United States and Mexico, 1997–1999, MMWR Morb Mortal Wkly Rep, 49, 1048

Panagiotopoulos, 1999, Increase in congenital rubella occurrence after immunisation in Greece: retrospective survey and systematic review, BMJ, 319, 1462, 10.1136/bmj.319.7223.1462

Edmunds, 2002, The effect of vaccination on the epidemiology of varicella zoster virus, J Infect, 44, 211, 10.1053/jinf.2002.0988

Brisson, 2002, Varicella vaccine and shingles, JAMA, 287, 2211, 10.1001/jama.287.17.2211

Edmunds, 1999, Evaluating the cost-effectiveness of vaccination programmes: a dynamic perspective, Stat Med, 18, 3263, 10.1002/(SICI)1097-0258(19991215)18:23<3263::AID-SIM315>3.0.CO;2-3

Lipsitch, 2000, The epidemiology of antibiotic resistance in hospitals: paradoxes and prescriptions, Proc Natl Acad Sci U S A, 97, 1938, 10.1073/pnas.97.4.1938

Adam, 2010, Changing epidemiology of invasive Haemophilus influenzae in Ontario, Canada: evidence for herd effects and strain replacement due to Hib vaccination, Vaccine, 28, 4073, 10.1016/j.vaccine.2010.03.075

Hanage, 2007, Diversity and antibiotic resistance among nonvaccine serotypes of Streptococcus pneumoniae carriage isolates in the post-heptavalent conjugate vaccine era, J Infect Dis, 195, 347, 10.1086/510249

Samore, 2006, Mechanisms by which antibiotics promote dissemination of resistant pneumococci in human populations, Am J Epidemiol, 163, 160, 10.1093/aje/kwj021

Jit, 2011, Modelling the epidemiology of infectious diseases for decision analysis: a primer, Pharmacoeconomics, 29, 371, 10.2165/11539960-000000000-00000

Kim, 2008, Cost-effectiveness analyses of vaccination programmes: a focused review of modelling approaches, Pharmacoeconomics, 26, 191, 10.2165/00019053-200826030-00004

Van de Velde, 2010, Understanding differences in predictions of HPV vaccine effectiveness: a comparative model-based analysis, Vaccine, 28, 5473, 10.1016/j.vaccine.2010.05.056

Ajelli, 2010, Comparing large-scale computational approaches to epidemic modeling: agent-based versus structured metapopulation models, BMC Infect Dis, 10, 190, 10.1186/1471-2334-10-190

Brooks-Pollock, 2010, The impact of realistic age structure in simple models of tuberculosis transmission, PLoS One, 5, e8479, 10.1371/journal.pone.0008479

Perez, 2009, An agent-based approach for modeling dynamics of contagious disease spread, Int J Health Geogr, 8, 50, 10.1186/1476-072X-8-50

Beutels, 2008, Funding of drugs: do vaccines warrant a different approach?, Lancet Infect Dis, 8, 727, 10.1016/S1473-3099(08)70258-5

van Hoek, 2012, The cost-effectiveness of varicella and combined varicella and herpes zoster vaccination programmes in the United Kingdom, Vaccine, 30, 1225, 10.1016/j.vaccine.2011.11.026

Foss, 2009, Dynamic modeling of herpes simplex virus type-2 (HSV-2) transmission: issues in structural uncertainty, Bull Math Biol, 71, 720, 10.1007/s11538-008-9379-1

Jit, 2011, Human papillomavirus vaccine introduction in low-income and middle-income countries: guidance on the use of cost-effectiveness models, BMC Med, 9, 54, 10.1186/1741-7015-9-54

Brunham, 2005, The unexpected impact of a Chlamydia trachomatis infection control program on susceptibility to reinfection, J Infect Dis, 192, 1836, 10.1086/497341

Vickers, 2010, Current crisis or artifact of surveillance: insights into rebound chlamydia rates from dynamic modelling, BMC Infect Dis, 10, 70, 10.1186/1471-2334-10-70

Medley, 2001, Hepatitis-B virus endemicity: heterogeneity, catastrophic dynamics and control, Nat Med, 7, 619, 10.1038/87953

Heijne, 2011, The role of reinfection and partner notification in the efficacy of chlamydia screening programs, J Infect Dis, 203, 372, 10.1093/infdis/jiq050

van Boven, 2005, Pathogen adaptation under imperfect vaccination: implications for pertussis, Proc Biol Sci, 272, 1617, 10.1098/rspb.2005.3108

Fraser, 2004, Factors that make an infectious disease outbreak controllable, Proc Natl Acad Sci U S A, 101, 6146, 10.1073/pnas.0307506101

Anderson, 1985, Age-related changes in the rate of disease transmission: implications for the design of vaccination programmes, J Hyg (Lond), 94, 365, 10.1017/S002217240006160X

Zagheni, 2008, Using time-use data to parameterize models for the spread of close-contact infectious diseases, Am J Epidemiol, 168, 1082, 10.1093/aje/kwn220

Johnson, 2001, Sexual behaviour in Britain: partnerships, practices, and HIV risk behaviours, Lancet, 358, 1835, 10.1016/S0140-6736(01)06883-0

Halloran, 2010, Assessing indirect, total, and overall effects

Saccomani, 2011, An effective automatic procedure for testing parameter identifiability of HIV/AIDS models, Bull Math Biol, 73, 1734, 10.1007/s11538-010-9588-2

Fisman, 2009, Modelling an influenza pandemic: a guide for the perplexed, CMAJ, 181, 171, 10.1503/cmaj.090885

Moghadas, 2011, Canada in the face of the 2009 H1N1 pandemic, Influenza Other Respi Viruses, 5, 83, 10.1111/j.1750-2659.2010.00184.x

van Rossum, 2008, [Vaccines against human papillomavirus (HPV): between registration and implementation], Ned Tijdschr Geneeskd, 152, 987

Halloran, 2008, Modeling targeted layered containment of an influenza pandemic in the United States, Proc Natl Acad Sci U S A, 105, 4639, 10.1073/pnas.0706849105

Hutubessy, 2011, Results from evaluations of models and cost-effectiveness tools to support introduction decisions for new vaccines need critical appraisal, BMC Med, 9, 55, 10.1186/1741-7015-9-55

Mossong, 2008, Social contacts and mixing patterns relevant to the spread of infectious diseases, PLoS Med, 5, e74, 10.1371/journal.pmed.0050074

Fenton, 2001, Sexual behaviour in Britain: reported sexually transmitted infections and prevalent genital Chlamydia trachomatis infection, Lancet, 358, 1851, 10.1016/S0140-6736(01)06886-6

Burden, 1989

Thông tin
Thông tin xuất bản

Value in Health

Tập 15

828-834

Thông tin tác giả